A computerized clinical decision support tool implemented as a diagnostic stewardship intervention led to an approximate 50% decrease in urine culture testing for patients with a urinary catheter, ...

A new study investigates the role of Krüppel-like factor 2 (KLF2, a protein coding gene involved in a variety of regulatory ...

Ongoing commercial launch of AUCATZYL® on track, with 24 treatment centers fully authorized as of January 10th- National Comprehensive Cancer ...

X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, ...

X4 to receive a €28.5 million upfront payment and up to €226 million in potential regulatory and commercial milestone payments in addition to tiered ...

However, Mr Jervis only received a course of antibiotics some 20 hours after it was noted that he needed the medication. Mr ...

For patients with relapsed or refractory multiple myeloma, talquetamab plus teclistamab shows response in a high perc ...

Seres Therapeutics, Inc. (Nasdaq: MCRB) (Seres or the Company), a leading live biotherapeutics company, today announced new ...

The Arch-backed startup begins life with several assets acquired from Denali Therapeutics. Elsewhere, Jasper got a negative ...

Physiomics said its software was initially developed to help clinicians with chemotherapy dosing decisions, but the results of a Partner study in January 2023 indicated that the software could be ...

Mathematical modelling, data science and biostatistics specialist Physiomics announced on Wednesday that its Innovate ...